- Report
- January 2024
- 310 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- December 2023
- 195 Pages
Global
€4546EUR$4,995USD£3,861GBP
- Report
- November 2023
- 29 Pages
United States
€2275EUR$2,500USD£1,933GBP
- Report
- September 2023
- 101 Pages
North America
From €2685EUR$2,950USD£2,281GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2685EUR$2,950USD£2,281GBP
- Report
- September 2023
- 112 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- September 2023
- 114 Pages
Global
From €2685EUR$2,950USD£2,281GBP
- Report
- September 2023
- 194 Pages
Global
From €4505EUR$4,950USD£3,827GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- November 2022
- 160 Pages
Global
€3095EUR$3,400USD£2,628GBP
- Report
- June 2022
- 215 Pages
United States
From €2457EUR$2,699USD£2,086GBP
- Report
- December 2020
- 20 Pages
United States
€1411EUR$1,550USD£1,198GBP
- Report
- October 2020
- 57 Pages
Global
- Report
- July 2020
- 213 Pages
Global, China
From €2913EUR$3,200USD£2,474GBP
- Report
- April 2020
- 165 Pages
Global
From €1265EUR$1,390USD£1,075GBP
- Report
- January 2019
- 12 Pages
Global
From €9102EUR$10,000USD£7,731GBP
- Report
- January 2019
- 12 Pages
Global
From €9102EUR$10,000USD£7,731GBP
- Report
- January 2019
- 14 Pages
Global
From €9102EUR$10,000USD£7,731GBP
- Report
- July 2018
- 224 Pages
Global
From €1229EUR$1,350USD£1,044GBP
€1638EUR$1,800USD£1,392GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,119USD£3,077GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more